Biopharma Competition Healthcare Physicians 
Clarivate
APRIL 18, 2024
Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.
PM360
APRIL 22, 2024
In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. From important changes to engaging physicians to finding out how new technologies will help address HCPs education needs, hear what our specialist had to say.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
APRIL 24, 2023
healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. In January 2023, VillageMD acquired Summit Health for $8.9 billion (with investments from Cigna’s Evernorth subsidiary).
Clarivate
JULY 5, 2023
The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S. By end of year, as many as ten adalimumab biosimilars could be on the U.S. from 91% in 2023 to 36% by 2031.
Clarivate
OCTOBER 25, 2023
Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e., exclusions exist for orphan drug designation and biosimilar competition ). Nonetheless, Clarivate expects the initial list to include oncology treatments KEYTRUDA® and OPDIVO®.
Clarivate
DECEMBER 6, 2022
In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.
PM360
NOVEMBER 27, 2023
I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. Pooja Ojala: How do you approach marketing to adapt to today’s healthcare landscape?
Expert insights. Personalized for you.
52 
Let's personalize your content